

Mossberry, Sassamanash, bounceberry
Cranberry is the fruit of a shrub and has been used in the form of juice to treat urinary tract infections (UTIs). Clinical evidence supports the claim that cranberry juice can prevent UTIs in adults (3) (27)and in children (28). This effect has been shown to be due to tannins in cranberries known as proanthocyanidins that inhibit the adherence of E. coli fimbriae to uroepithelial cells (4) (5). However, regular consumption of cranberry juice for six months did not confer protection against UTIs (30). In another study, patients who took cranberry were more likely to have a recurrent UTI, but did not develop antibiotic resistant bacteria, compared to those who used trimethoprim-sulfamethoxazole (32).
Cranberry extracts demonstrated anti-proliferative effects against prostate (10) (11), liver (12), breast (13), colon (11) (14), and oral (11) cancer cell lines in vitro.
Cranberry juice also inhibited the adhesion of H. pylori to human gastric mucosa (7). A trial done in China suggests that regular consumption of cranberry juice can suppress H. pylori infection, a major factor in peptic ulcer disease and gastric cancer (6).
Cranberry juice has also been shown to prevent plaque formation and the development of gum disease due to its anti-colonizing and anti-adhesion properties (8) (9).
Proanthocyanidins found in cranberries inhibit P-fimbriated E. coli from adhering to the uroepithelial cells, thus preventing the development of an infection (4) (5) (16) (17). Research suggests that the high number of A-type linkage proanthocyanidins found in cranberries may enhance the in vitro and urinary bacterial anti-adhesion activities that prevent UTIs (18). A constituent of cranberry juice has been shown to inhibit adhesion of H. pylori to immobilized human mucus, human erythrocytes, and cultured gastric epithelial cells, suggesting that cranberry juice may also prevent stomach ulcers caused H. pylori by preventing the adhesion of the bacteria to the stomach lining (7) (19). Cranberry juice was also shown to decrease adherence of oral streptococci strains to saliva-coated hydroxyapatite (8) (20), glucan-coated hydroxyapatite (20), and impaired biofilm formation (9) (20) suggesting that cranberry juice may slow the development of dental plaque and offer protection from plaque-related diseases.
The total polyphenol fraction of cranberry extract was the most active against oral, colon, and prostate cell lines (11). The specific molecular mechanisms of the anticancer properties of cranberry extracts remain unknown.
Case Reports
Several cases of increased INR (33) (34) and/or bleeding due to suspected interactions involving warfarin and cranberry juice (15) have been reported.
Two patients suffered internal hemorrhage following concurrent use of warfarin and cranberry juice that resulted in their deaths (23) (35).
Beerepoot MAJ, Riet GT, Nys S, et al. Cranberries vs Antibiotics to Prevent Urinary Tract Infections. A Randomized Double-blind Noninferiority Trial in Premenopausal Women. Arch Intern Med. 2011;171(14):1270-1278.
In this study, 221 premenopausal women with recurrent urinary tract infections (UTIs) were randomized to recieve trimethoprim-sulfamethoxazole (TMP-SMX), 480 mg once daily, or cranberry capsules, 500mg twice daily for one year. The primary end points were the mean number of symptomatic UTIs, the proportion of patients with atleast 1 symptomatic UTI, the median time to first UTI, and development of antibiotic resistance in indigenous Escherichia coli. Researchers observed the mean number and proportion of patients with at least 1 symptomatic UTI to be higher in the cranberry group. The median time to first symptomatic UTI was 4 and 8 months for the cranberry and TMP-SMX groups respectively. However, increased resistance was observed for TMP-SMX, trimethoprim, amoxicillin, and ciproflaxin in the E.coli isolates in the TMP-SMX group. No such increases were seen in women who took cranberry.
TMP-SMX is more effective than cranberry capsules in preventing recurrent UTIs but antibiotic resistance is a major concern.
Barbosa-Cesnik C, Brown MB, Buxton M, et al. Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial. Clin Infect Dis. 2011 Jan;52(1):23-30.
In this double-blind, placebo-controlled trial 319 college-aged women with acute urinary tract infection (UTI) were randomized to receive 8 ounces of 27% cranberry juice twice daily or placebo for six months. The subjects were followed up for 6 months or until the occurrence of a second UTI. Researchers failed to find any significant differences in urinary symptoms between the treatment and placebo groups at follow-up. Although small studies have reported the benefits of cranberry juice for prevention of UTIs, large randomized studies are lacking. Further research is needed to determine the usefulness of cranberry juice.
Zhang L, Ma J, Pan K, Go VL, Chen J, You WC. Efficacy of cranberry juice on Helicobacter pylori infection: a double-blind, randomized placebo-controlled trial. Helicobacter 2005;10(2):139-45.
This randomized, double-blind, placebo-controlled trial was conducted to test the effectiveness of cranberry juice in the suppression of H. pylori in an endemically infected population. One hundred and eighty seven adults with H. pylori infection were randomly assigned to receive cranberry juice or a placebo for 90 days. The extent of H. pylori infection was determined using the 13C-urea breath test. The study concluded that significantly more subjects in the cranberry juice group (14.43%) than the placebo group (5.44%) yielded negative test results, suggesting that regular consumption of cranberry juice can suppress H. pylori infection in endemically infected populations.
Bottom Line: Cranberry juice has not been shown to treat or cure cancer.
Cranberries contain compounds known as proanthocyanidins that have been shown to inhibit E. coli from adhering to the bladder wall, thus preventing the development of an infection. Cranberry juice has also been shown to inhibit the adherence of oral bacteria in the laboratory setting, suggesting that it may slow the development of dental plaque and offer some protection from plaque-related diseases.
Prevention of UTIs:
In this study, 221 premenopausal women with recurrent urinary tract infections (UTIs) were randomized to recieve trimethoprim-sulfamethoxazole (TMP-SMX), 480 mg once daily, or cranberry capsules, 500mg twice daily for one year. The primary end points were the mean number of symptomatic UTIs, the proportion of patients with atleast 1 symptomatic UTI, the median time to first UTI, and development of antibiotic resistance in indigenous Escherichia coli. Researchers observed the mean number and proportion of patients with at least 1 symptomatic UTI to be higher in the cranberry group. The median time to first symptomatic UTI was 4 and 8 months for the cranberry and TMP-SMX groups respectively. However, increased resistance was observed for TMP-SMX, trimethoprim, amoxicillin, and ciproflaxin in the E.coli isolates in the TMP-SMX group. No such increases were seen in women who took cranberry.
TMP-SMX is more effective than cranberry capsules in preventing recurrent UTIs but antibiotic resistance is a major concern.
In a double-blind, placebo-controlled trial 319 college-aged women with acute urinary tract infection (UTI) received 8 ounces of 27% cranberry juice twice daily or placebo for six months. The subjects were followed up for 6 months or until the occurrence of a second UTI. Researchers failed to find any significant differences in urinary symptoms between the treatment and placebo groups at follow-up. Although small studies have reported the benefits of cranberry juice for prevention of UTIs, large randomized studies are lacking. Further research is needed to determine the usefulness of cranberry juice.
A study of 150 women with UTIs caused by E. coli were given 50ml of cranberry-lingonberry juice concentrate a day for six months, an intervention of 100ml of lactobacillus drink five days a week for one year, or no intervention. The study showed that the cranberry group had a 20% risk reduction of UTI recurrence, suggesting that regular drinking of cranberry juice may reduce the recurrence of UTIs. A study of 150 patients showed that cranberry juice and cranberry tablets both decreased the number of patients experiencing at least one UTI per year when compared to placebo. Tablets were taken twice a day and 250ml of juice was taken three times a day for the one year trial. The study also concluded that tablets provided a more cost effective prevention of UTI compared to cranberry juice.
This product is regulated by the FDA as a dietary supplement. Unlike approved drugs, supplements are not required to be manufactured under specific standardized conditions. This product may not contain the labeled amount or may be contaminated. In addition, it may not have been tested for safety or effectiveness.